Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia
Over-the-Counter antioxidant lipoic acid holds promise in improving patients’ lives after an OHSU pilot study. Treatment options currently are limited for people suffering from secondary progressive MS. The randomized double-blind study involved 51 participants who completed the 2-year trial. 27 people were given a 1,200-milogram daily dose of lipoic acid, with the remaining 24 participants given a placebo. Researchers are using the findings from the pilot trial to design the expanded multi-site clinical trial to begin later this year in Portland and other sites that have yet to be finalized.
“These are high doses,” said Rebecca Spain, M.D...
Read More
Recent Comments